SAFETY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): INTEGRATED ANALYSIS OF CUMULATIVE DATA FROM 5 CLINICAL TRIALS

被引：0

作者：

Noble, P. W. ^{[1
]}

Albera, C. ^{[2
]}

Bradford, W. Z. ^{[3
]}

Costabel, U. ^{[4
]}

Glaspole, I. ^{[5
]}

Glassberg, M. K. ^{[6
]}

Lederer, D. J. ^{[7
]}

Lin, Z. ^{[3
]}

Nathan, S. D. ^{[8
]}

Pereira, C. A. ^{[9
]}

Swigris, J. J. ^{[10
]}

Valeyre, D. ^{[11
]}

Lancaster, L. ^{[12
]}

机构：

[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[2] Univ Turin, Turin, Italy

[3] InterMune Inc, Brisbane, CA USA

[4] Ruhrlandklin, Essen, Germany

[5] Alfred Hosp, Melbourne, Vic, Australia

[6] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

[7] Columbia Univ, New York, NY USA

[8] Inova Fairfax Hosp, Falls Church, VA USA

[9] Univ Fed Sao Paulo, Paulista Sch Med, Sao Paulo, Brazil

[10] Natl Jewish Hlth, Denver, CO USA

[11] Avicenne Univ Hosp, Bobigny, France

[12] Vanderbilt Univ, Med Ctr, Nashville, TN USA

来源：

THORAX | 2015年 / 70卷

关键词：

D O I：

10.1136/thoraxjnl-2015-207770.150

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

P13

引用

页码：A80 / A81

页数：2

共 50 条

[1] Safety Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis (ipf): Integrated Analysis Of Data From 5 Clinical Trials
Lancaster, L.
Albera, C.
Bradford, W. Z.
Costabel, U.
Du Bois, R. M.
Fagan, E. A.
Glaspole, I.
Glassberg, M. K.
King, T. E.
Lederer, D. J.
Lin, Z.
Pereira, C. A.
Swigris, J. J.
Valeyre, D.
Noble, P. W.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
[2] Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials
Lancaster, Lisa
Albera, Carlo
Bradford, Williamson Z.
Costabel, Ulrich
du Bois, Roland M.
Fagan, Elizabeth A.
Fishman, Robert S.
Glaspole, Ian
Glassberg, Marilyn K.
King, Talmadge E., Jr.
Lederer, David J.
Lin, Zhengning
Nathan, Steven D.
Pereira, Carlos A.
Swigris, Jeffrey J.
Valeyre, Dominique
Noble, Paul W.
[J]. BMJ OPEN RESPIRATORY RESEARCH, 2016, 3 (01):
[3] Long-Term Safety Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis (ipf): Integrated Analysis Of Data From 4 Clinical Trials
Nathan, S. D.
Albera, C.
Bradford, W. Z.
Costabel, U.
du Bois, R. M.
Fagan, E. A.
Fishman, R.
Glaspole, I.
Glassberg, M. K.
King, T. E.
Lancaster, L.
Lederer, D. J.
Leff, J. A.
Pereira, C. A.
Sahn, S. A.
Swigris, J. J.
Noble, P. W.
Valeyre, D.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[4] Long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis of 4 clinical trials
Noble, Paul
Albera, Carlo
Lancaster, Lisa
Hormel, Phillip
Hulter, Henry
Costabel, Ulrich
[J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[5] Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF): Pooled Data from Six Clinical Trials
Lancaster, L. H.
Hernandez, P.
Inoue, Y.
Wachtlin, D.
Loaiza, L.
Conoscenti, C. S.
Quaresma, M.
Stowasser, S.
Richeldi, L.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[6] Safety of Combined Pirfenidone and Nintedanib in Subgroups of Patients with Idiopathic Pulmonary Fibrosis (IPF)
Flaherty, K.
Fell, C. D.
Huggins, J. T.
Nunes, H.
Sussman, R.
Valenzuela, C.
Petzinger, U.
Stauffer, J. L.
Gilberg, F.
Bengus, M.
Wijsenbeek, M.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[7] Pirfenidone: Clinical trials and clinical practice in patients with idiopathic pulmonary fibrosis
Bando, Masashi
[J]. RESPIRATORY INVESTIGATION, 2016, 54 (05) : 298 - 304
[8] Fatigue in patients with idiopathic pulmonary fibrosis (IPF) from the pooled pirfenidone (PFD) Phase III trials
Costabel, Ulrich
Albera, Carlo
Wijsenbeek, Marlies S.
de Andrade, Joao A.
Mason, Wendi R.
Nathan, Steven D.
Zibrak, Joseph D.
Padilla, Maria L.
Gilberg, Frank
Petzinger, Ute
Kirchgaessler, Klaus-Uwe
Lancaster, Lisa H.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[9] Effect of Pirfenidone on IPF-Related Mortality Outcome Measures in Patients With Idiopathic Pulmonary Fibrosis (IPF): Pooled Data Analysis From the ASCEND and CAPACITY Trials
Nathan, Steven
Albera, Carlo
Bradford, Williamson
Kardatzke, David
Costabel, Ulrich
du Bois, Roland
Glaspole, Ian
Glassberg, Marilyn
King, Talmadge
Kirchgaessler, Klaus-Uwe
Lancaster, Lisa
Lederer, David
Pereira, Carlos
Swigris, Jeffrey
Valeyre, Dominique
Noble, Paul
[J]. CHEST, 2015, 148 (04)
[10] The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
Valeyre, Dominique
Albera, Carlo
Bradford, Williamson
Costabel, Ulrich
King, Talmadge
Noble, Paul
Sahn, Steven
du Bois, Roland
[J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40

← 1 2 3 4 5 →